首页> 美国卫生研究院文献>Cell Death Disease >Mutual inhibition between HDAC9 and miR-17 regulates osteogenesis of human periodontal ligament stem cells in inflammatory conditions
【2h】

Mutual inhibition between HDAC9 and miR-17 regulates osteogenesis of human periodontal ligament stem cells in inflammatory conditions

机译:HDAC9和miR-17之间的相互抑制调节了炎症条件下人牙周膜干细胞的成骨作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Histone deacetylases (HDAC) plays important roles in the post-translational modifications of histone cores as well as non-histone targets. Many of them are involved in key inflammatory processes. Despite their importance, whether and how HDAC9 is regulated under inflammatory conditions remains unclear. The aim of this study was to evaluate the effects of HDAC9 under chronic inflammation condition in human periodontal ligament stromal cell (PDLSCs) and to explore the underlying regulatory mechanism. PDLSCs from healthy or periodontitis human tissue was compared. The therapeutic effects of HDAC inhibitors was determined in PDLSC pellet transplanted nude mice and LPS-induced rat periodontitis. We report that HDAC9 was the most affected HDAC family member under inflammatory conditions in PDLSCs. HDAC9 impaired osteogenic differentiation capacity of PDLSCs under inflammatory conditions. Downregulation of HDAC9 by HDAC inhibitors or si-HDAC9 rescued the osteogenic differentiation capacity of inflammatory PDLSC to a similar level with the healthy PDLSC. In this context, HDAC9 and miR-17 formed an inhibitory loop. The inhibition of miR-17 aggravated loss of calcified nodules in inflamed PDLSCs and interrupted the effect of HDAC inhibitor in rescuing osteogenesis. In vivo experiments using nude mice and LPS-induced periodontitis model confirmed that HDAC inhibitors could improve new bone formation. We conclude that HDAC inhibitors improved osteogenesis of PDLSCs in vitro and periodontitis in vivo.
机译:组蛋白脱乙酰基酶(HDAC)在组蛋白核心以及非组蛋白靶标的翻译后修饰中起重要作用。他们中的许多人都参与了关键的炎症过程。尽管它们很重要,但尚不清楚在炎症条件下是否以及如何调节HDAC9。这项研究的目的是评估HDAC9在慢性炎症条件下对人牙周膜间质细胞(PDLSC)的作用,并探讨其潜在的调控机制。比较了来自健康或牙周炎人体组织的PDLSC。在PDLSC颗粒移植裸鼠和LPS诱导的大鼠牙周炎中确定了HDAC抑制剂的治疗作用。我们报告HDAC9是PDLSCs中炎症条件下受影响最大的HDAC家族成员。在炎性条件下,HDAC9损害了PDLSC的成骨分化能力。 HDAC抑制剂或si-HDAC9对HDAC9的下调将炎症性PDLSC的成骨分化能力恢复到了与健康PDLSC相似的水平。在这种情况下,HDAC9和miR-17形成了一个抑制环。 miR-17的抑制加剧了发炎的PDLSC中钙化结节的丢失,并中断了HDAC抑制剂在挽救成骨中的作用。使用裸鼠和LPS诱导的牙周炎模型进行的体内实验证实,HDAC抑制剂可以改善新的骨骼形成。我们得出的结论是,HDAC抑制剂在体外改善了PDLSC的成骨作用,而在体内改善了牙周炎。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号